Congratulations to Pliant Board Director Katharine Knobil, M.D. for being recognized as member of the Directors to Watch Class of 2024 by Directors & Boards magazine. This recognition highlights Katharine's significant contributions to ensuring a robust board culture and maintaining corporate governance excellence. Congrats from all of #TeamPliant! Learn more about Katharine and this recognition: https://lnkd.in/gZz9GCyd
That's fantastic news! Congratulations to Katharine, on this well-deserved recognition. Her contributions to board culture and corporate governance at Pliant Therapeutics are truly commendable and reflect her leadership excellence. #BoardOfDirectors #CorporateGovernance Recruits Lab (We're hiring) BioJobs Lab
That's awesome!! Congrats Katharine Knobil, M.D.
Congrats!
Innovative Pharma Executive | Patient Advocate | Independent Board Member
1moI am so flattered to be nominated to the 2024 Directors to Watch from Directors&Boards! Many thanks to #TeamPliant for your support!